Pillar Biosciences, Inc. has received accreditation from the College of American Pathologists (CAP). “Pillar Biosciences is committed to delivering the highest quality, clinically actionable products and information to our biopharma partners, clinical clients and the patients they serve.” stated Randy Pritchard, CEO of Pillar Biosciences. “This CAP accreditation is an important milestone in our company’s mission to collaborate with biopharma to develop enabling technologies for cutting edge therapies and deliver NGS solutions that drive actionable, accessible results to everyone, everywhere.”
For the full article click here: Pillar Biosciences Receives College of American Pathologists (CAP) Accreditation